fashion -WSS

fashion

author：fashion 2025-08-23 08:52:55 - browse：48359

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Takeaways from AdvaMed, the largest medical devices conference

focus

explore

knowledge

WSS

How clinical AI models' predictive power can degrade over time

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

A new nitrogen execution bill also undermines medical licensing

STAT Readout: Today's biotech news includes Sana and Amylyx

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

There’s no way to know how good AI health technologies are

leisure time

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

What's changing in Medicare's open enrollment this year?

Drug repurposing or repositioning? The language matters

Bernie Sanders bashes nonprofit hospitals over their tax breaks

DIEP, the 'gold standard' of breast reconstruction, is under threat

How should state employee insurance handle Wegovy?

Activists slam private health insurers over coverage restrictions

Why palliative psychiatry is worth discussing

The high cost of giving birth even with insurance

Bernie Sanders bashes nonprofit hospitals over their tax breaks

focus

How doctors and nurses shape Google's AI

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

There’s no way to know how good AI health technologies are

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Massive project maps cells in human brain in unprecedented detail

Life sciences deals on track to hit lowest point since 2017

focus

explore

knowledge

focus